Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Protective Associations of HDL with Blood Brain Barrier Injury in Multiple Sclerosis Patients.
Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study.
MRI in multiple sclerosis: a review of the current literature.
Active Biotech announce that European Medicines Agency accepts start of scientific review of the marketing authorization application for laquinimod in relapsing-remitting multiple sclerosis
Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design.
Frequency of obsessive-compulsive disorder in patients with multiple sclerosis: A cross-sectional study.
Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).
Atypical guillain-barré syndrome misdiagnosed as lumbar spinal stenosis.
Minocycline treatment for rheumatoid arthritis: an open dose finding study.
Disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study.
Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials.
Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis.
An Inventory of Short Term and Long Term Changes in Gene Expression Under Interferon β Treatment of Relapsing Remitting MS Patients.
Autoimmune myelopathies.
Expression of IL-33 and its epigenetic regulation in Multiple Sclerosis.
Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis.
Endogenous retroviruses and multiple sclerosis--new pieces to the puzzle.
Intermittent feeding attenuates clinical course of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Association mapping of disease loci, by use of a pooled DNA genomic screen.
Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features.
Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment.
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study.
UPDATE 2-FDA panel supports approval of Sanofi's MS drug Lemtrada
Activities of daily living: evaluation and treatment in persons with multiple sclerosis.
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.

Pages